Company Data

Travere Therapeutics Inc.

Ticker
TVTX
Current Price
$23.33 2.96%
Market Cap
$1.8B
Price Target
Refer to Report
Volume
1.5M
52wk Range
$5.12 - $25.29
Advanced Market Data

Overview

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) – rare kidney disorders that often lead to end-stage kidney disease.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy